Home
Shares
News Centre
F&O
Mutual Funds
IPO
Portfolio
Commodity
Loans
Financial Planning
Insurance
About Us
Markets
Companies
Research
Industries
E-Mail Page
Get NAV
Snapshot
Portfolio
Dividends
News
Interviews
Charts
Get Quote
Snapshot
Charts
Financials
Research
News
Wealth Tracker
Tax Corner
NRI Centre
Chat Masala
Feedback
my
Last 5 Scrips
Company
BSE Price(Rs)
% Chg
Yes Bank
24.08
42.49
Tata Stl
136.20
30.33
Ong Corp
256.00
95.64
I T C Lt
438.65
28.62
Ntpc Ltd
319.00
89.15
Clear All
Clear Last
Equity
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
News Watch
Sector Watch
Economy Watch
News-Zydus Lifesciences Limited
Zydus Lifesciences Limited
Sector:Pharmaceuticals
Pharmaceuticals - Formulations
BSE:
532321
NSE:
ZYDUSLIFE
Bloomberg:
CDH@IN
Reuters:
CADI.BO
Market Lot: 1
Face Value: 1
ISIN Demat: INE010B01027
Quotes
Snapshot
Charts
Financials
Research
Recent News
Peer Group
AGM/AM
MF Holding
Discussion Forum
BSE/NSE Notices
BSE/NSE Deals
Corporate News
10-Mar-2022
Zydus gets final nod from USFDA for Nitroglycerin Sublingual Tablets
IRIS
09-Mar-2022
Zydus Lifesciences arm executes asset purchase agreement with BridgeBio
IRIS
23-Feb-2022
Cadila Healthcare gets final nod from USFDA for Dapagliflozin Tablets
IRIS
02-Feb-2022
Zydus supplies first consignment of COVID-19 vaccine ZyCoV-D
IRIS
13-Dec-2021
Zydus gets approval for Phase II Clinical study in patients with CAPS in Australia
IRIS
22-Nov-2021
Cadila Healthcare gets final approval from USFDA for Decitabine Injection
IRIS
12-Nov-2021
Cadila receives tentative approval from USFDA for Eluxadoline Tablets
IRIS
21-Sep-2021
Cadila Healthcare arm inks pact with Integrace
IRIS
20-Aug-2021
Cadila Healthcare partners with CHEMI of Italy
IRIS
20-Aug-2021
Cadila Healthcare partners with CHEMI of Italy
IRIS
13-Aug-2021
Cadila gets final USFDA nod for Mesalamine Extended-Release Capsules
IRIS
25-Jun-2021
Cadila receives USFDA nod for chemotherapy drug
IRIS
21-Jun-2021
Zydus and Bayer extend joint venture by three years
IRIS
02-Jun-2021
Zydus Cadila gets final nod from USFDA for Fluphenazine Hydrochloride Tablets
IRIS
28-May-2021
Zydus Cadila introduces IT enabled scratch code on product packs
IRIS
26-May-2021
Zydus, TLC to market antifungal drug Liposomal Amphotericin B
IRIS
12-May-2021
Cadila Healthcare enters into BTA with Zenex Animal Health
IRIS
05-May-2021
Cadila Healthcare extends tenure of JV with Bayer
IRIS
09-Apr-2021
Zydus Cadila gets USFDA approval for Ibrutinib Capsules
IRIS
07-Apr-2021
Zydus seeks DCGI approval for a hepatitis drug to treat COVID-19
IRIS
Home
|
Shares
|
F&O
|
Mutual Funds
|
Loans
|
Insurance
|
News Centre
Wealth Tracker
|
Tax Corner
|
NRI Centre
|
Search in myiris
|
Advertise
� All rights reserved. IRIS Business Services Limited
Disclaimer